Vericel (VCEL) Net Income Growth (1y) (2011 - 2026)
Vericel (VCEL) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,802.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 41.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.85% |
| Dec 31, 2025 | 21.87% |
| Sep 30, 2025 | 614.21% |
| Jun 30, 2025 | 80.63% |
| Mar 31, 2025 | -171.78% |
| Dec 31, 2024 | 52.44% |
| Sep 30, 2024 | 75.38% |
| Jun 30, 2024 | 90.79% |
| Mar 31, 2024 | 45.66% |
| Dec 31, 2023 | 119.40% |
| Sep 30, 2023 | 44.35% |
| Jun 30, 2023 | -523.47% |
| Mar 31, 2023 | -12.30% |
| Dec 31, 2022 | 30.58% |
| Sep 30, 2022 | -33.38% |
| Jun 30, 2022 | -136.74% |
| Mar 31, 2022 | -115.60% |
| Dec 31, 2021 | -62.89% |
| Sep 30, 2021 | -236.29% |
| Jun 30, 2021 | 54.21% |